// Auto-generated - do not edit
export const substanceName = "AM-2201";
export const sources = [{"id":"drugusersbible","fileName":"DRUGUSERSBIBLE - AM-2201.md","displayName":"Drug Users Bible","size":2502},{"id":"protestkit","fileName":"PROTESTKIT - AM-2201.json","displayName":"Protest Kit","size":1722},{"id":"tripsit-factsheets","fileName":"TRIPSIT_FACTSHEETS - AM-2201.md","displayName":"TripSit Factsheets","size":559},{"id":"wikipedia","fileName":"WIKIPEDIA - AM-2201.md","displayName":"Wikipedia","size":1291}];
export const contents: Record<string, string> = {
  "drugusersbible": `# AM-2201
*Source: Drug Users Bible by Dominic Milton Trott*

*Section 2.8.2 - CHEMSCAPE: A Chemical Journey*

## Quick Reference
- **Common Nomenclature:** 1 - (5-fluoropentyl)- 3 - (1-naphthoyl)indole
- **Street & Reference Names:** Black Mamba
- **Reference Dosage:** Light 250ug+; Moderate 500ug+; Heavy 1mg+
- **Anticipated: Onset / Duration:** 2 0 Seconds / 2 Hours
- **Maximum Dose Experienced:** Unknown
- **Form:** Smoking Mixture
- **RoA:** Smoked
- **Source / Jurisdiction:** Head Shop / UK

## Subjective Experience

Like spice, the brand name Black Mamba was eventually to be misappropriated to
become a generic name for all sorts of materials infused with a strong cannabinoid or
combinations of strong cannabinoids. Originally, however, it appeared in a green and
black glossy packet, infused with just AM-2201.

It was a monster.

In 2014 I posted the following on an Internet forum, as a response to a member who
had articulated his own terrible story with the same compound:

\`\`\`
I had a very similar experience with this chemical, which I bought as an
incense blend from a head shop. I tested it twice, optimistically and foolishly
assuming that the first bad hit was a fluke.
\`\`\`

\`\`\`
I felt the sort of anxiety that is possible via certain cannabis strains; but
multiplied by a factor of 100. It was almost overwhelming: acute fear and
intense paranoia are good words to describe it.
\`\`\`
\`\`\`
After this second lesson, I flushed the rest of the bag. I still struggle to explain
how it took two trips to the abyss to do this.
\`\`\`
\`\`\`
The other cannabinoid that freaked me out was 5F-AKB48, which was also
smoked courtesy of a head-shop procured blend. After the nightmare with that
one, that was it: no more synthetic cannabinoids, ever.
\`\`\`
\`\`\`
The sheer terror I endured with these two is hard to articulate, and I didn't
even consume them in vast quantities.
\`\`\`
On each occasion, the intensity of the dread eventually subsided, and the experience
plateaued into a more regular cannabinoid-type state. Each had been a +++ on the
Shulgin scale and an absolutely horrendous ride.

I shudder to think about what may have occurred had all this unfolded in a public
place, rather than in the sanctuary of my home.

Note that I have in fact held true to my forum comment above: I have not sampled an
artificial cannabinoid since that particular day.

\`\`\`
This was one of the cannabinoids which was central to the surge of addiction
amongst the homeless in British cities circa 2017
\`\`\`
`,
  "protestkit": `{
  "url": "https://drugs.tripsit.me/am-2201",
  "experiencesUrl": "https://www.reddit.com/search/?q=AM-2201",
  "name": "AM-2201",
  "aliases": [
    "am2201"
  ],
  "aliasesStr": "am2201",
  "summary": "A synthetic cannabanoid that is very potent. Active doses start at around 250ug's. Please be cautious with this substance. It has also been noted that it can cause convulsions.",
  "reagents": null,
  "classes": {
    "chemical": [],
    "psychoactive": []
  },
  "toxicity": null,
  "addictionPotential": null,
  "tolerance": null,
  "crossTolerances": null,
  "roas": [
    {
      "name": "Vapourized",
      "dosage": [
        {
          "name": "Light",
          "value": "250-500ug"
        },
        {
          "name": "Common",
          "value": "500-1000ug"
        },
        {
          "name": "Strong",
          "value": "1000-2000ug"
        }
      ],
      "duration": [
        {
          "name": "Onset",
          "value": "1.0 - 3.0 minutes"
        },
        {
          "name": "Duration",
          "value": "30.0 - 90.0 minutes"
        },
        {
          "name": "After effects",
          "value": "15.0 - 60.0 minutes"
        }
      ]
    },
    {
      "name": "Oral",
      "duration": [
        {
          "name": "Onset",
          "value": "15.0 - 30.0 minutes"
        },
        {
          "name": "Duration",
          "value": "60.0 - 180.0 minutes"
        },
        {
          "name": "After effects",
          "value": "15.0 - 60.0 minutes"
        }
      ]
    }
  ],
  "interactions": null,
  "effects": null,
  "categorized_effects": {
    "Physical effects": [],
    "Mental effects": [],
    "Sensory effects": [],
    "Uncategorized effects": []
  }
}`,
  "tripsit-factsheets": `# AM-2201
*Source: TripSit Factsheets (tripsit.me)*

## Summary

A synthetic cannabanoid that is very potent. Active doses start at around 250ug's. It is recommended to be cautious with this substance. It has also been noted that it can cause convulsions.

## Classification
- **Categories:** research-chemical, tentative, habit-forming
- **Also known as:** am2201

## Dosage

### Vapourized
- **Common:** 500-1000ug
- **Light:** 250-500ug
- **Strong:** 1000-2000ug

## Duration
- **Onset:** minutes
- **Duration:** minutes
- **After Effects:** 15-60 minutes
`,
  "wikipedia": `# AM-2201
*Source: https://en.wikipedia.org/wiki/AM-2201*

AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.

## Hazards

Convulsions have been reported including at doses as low as 10 mg.

## Pharmacology

AM-2201 is a full agonist for cannabinoid receptors. Affinities are: with a Ki of 1.0 nM at CB1 and 2.6 nM at CB2. The 4-methyl functional analog MAM-2201 probably has similar affinities. AM-2201 has an EC50 of 38 nM for human CB1 receptors, and 58 nM for human CB2 receptors. AM-2201 produces bradycardia and hypothermia in rats at doses of 0.3â€“3 mg/kg, comparable to the potency of JWH-018 in rats, suggesting potent cannabinoid-like activity.

### Pharmacokinetics

AM-2201 metabolism differs only slightly from that of JWH-018. AM-2201 N-dealkylation produces fluoropentane instead of pentane (or plain alkanes in general).

## Detection

A forensic standard of AM-2201 is available, and the compound has been posted on the Forendex website of potential drugs of abuse.

## Legal status

In the United States, AM-2201 is a Schedule I controlled substance.
`,
};
